logo
Select company
Select metric
$ 1.73EBITDA per Share
VS
Market
53
Sector
85
Industry
96
History
90
$ 1.65Close
$ 0.67 - $ 1.82 52-Week Range
Ticker Information

Ticker

CHRS

Company Name

COHERUS ONCOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

COHERUS ONCOLOGY INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CHRS - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ 200.92M$ 1.731116.08M
3/31/2025$ -106.54M$ -0.921115.86M
12/31/2024$ 62.34M$ 0.541114.55M
9/30/2024$ 37.75M$ 0.331115.21M
6/30/2024$ 13.47M$ 0.121114.82M
3/31/2024$ -10.9M$ -0.11112.75M
12/31/2023$ -191.46M$ -2.03194.16M
9/30/2023$ -172.39M$ -1.76197.74M
6/30/2023$ -222.39M$ -2.55187.27M
3/31/2023$ -234.3M$ -2.96179.27M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • COHERUS ONCOLOGY INC's latest trailing twelve months (TTM) EBITDAPS stands at $ 2.67.
  • Over the past 5 years, COHERUS ONCOLOGY INC's average EBITDAPS has been $ -1.12.
  • The median EBITDAPS for COHERUS ONCOLOGY INC during this period was $ -1.78
  • COHERUS ONCOLOGY INC reached its highest EBITDAPS over the past 5 years at $ 2.67.
  • The lowest EBITDAPS recorded by COHERUS ONCOLOGY INC in the same timeframe $ -3.43

COHERUS ONCOLOGY INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
MGNX : MACROGENICS INC $ -0.44IGMS : IGM BIOSCIENCES INC $ -0.68STRO : SUTRO BIOPHARMA INC $ -2.01AGEN : AGENUS INC $ -2.49ATRA : ATARA BIOTHERAPEUTICS INC $ 2.04CELU : CELULARITY INC $ -2.42CSBR : CHAMPIONS ONCOLOGY INC $ 0.32KPTI : KARYOPHARM THERAPEUTICS INC $ -9.1IPSC : CENTURY THERAPEUTICS INC $ -0.09IVVD : INVIVYD INC $ -0.89

Similar metrics to Shares WA:

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for COHERUS ONCOLOGY INC is calculated as follows: EBITDA [ $ 191.35M ] / (Shares WA [ 71.65M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ 2.67 ]

CHRS - EBITDA per Share, Last 5 years

$ -3.43

Minimum

Dec 31, 2021

$ 2.67

Maximum

Sep 30, 2020

$ -1.12

Average

$ -1.78

Median

EBITDAPS Benchmark Analysis

 The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -10.86
max$ 13.95
average$ 2.01
median$ 0.99
std$ 4.26